Solid phase synthesis of novel pyrrolidinedione analogs as potent HIV-1 integrase inhibitors

Journal of Combinatorial Chemistry

Volumn 12, Issue 1, 2010, Pages 84-90

  Pendri, Annapurna ^a   Troyer, Timothy L ^a   Sofia, Michael J ^a   Walker, Michael A ^a   Narasimhulu Naidu, B ^a   Banville, Jacques ^a   Meanwell, Nicholas A ^a   Dicker, Ira ^a   Lin, Zeyu ^a   Krystal, Mark ^a   Gerritz, Samuel W ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE INHIBITOR; SUCCINIMIDE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG DESIGN; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; METHODOLOGY; SYNTHESIS;

COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; HIV INTEGRASE INHIBITORS; HIV-1; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; SUCCINIMIDES;

EID: 74049137864     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc9001026     Document Type: Article

References (36)

1. (a) Greene, W. C.; Debyser, Z.; Ikeda, Y.; Freed, E. O.; Stephens, E.; Yonemoto, W.; Buckheit, R. W.; Este, J. A.; Cihlar. T. Antiviral Res. 2008, 80, 251-265.
2. (b) Young, S. D. Annu, Rev. Med. Chem. 2003, 38, 173-182
3. (c) De clercq, E. Int. J. Biochem, Cell Biol. 2004, 36, 1800-1822.
4. (d) Este, J. A. chem, Med, Chem. 2003, 10,1617-1632.
5. (a) Nair. V.; Chi, G. Rev. Med., virol- 2007, 17, 277-295.
6. (b) Evering, T. H.; Markowitz, M. Expert Qpin. Invest, Drugs 2008, 17, 413-422.
7. (c) Pais, G. C. G.; Burke, T. R., Jr. Drues Future 2002, 27, 1101-1111.
8. (d) Chiu, T. K.; Davies, D. R. Curr. Ton. Med. Chem. 2004, 4, 965-979.
9. Wai, J. S.; Egbertson, M. S.; Payne, L. S.; Fisher, T. E.; Embrey, M. W.; Tran, L. O.; Melamed, J. Y.; Langford, H. M.; Guare, J. P., Jr.; Zhuang, L.; Grey, V. E.; Vacca, J. P.; Holloway, M. K.; Naylor-Olsen, A. 1. M.; Hazed, D. J.; Felock, P. J.; Wolfe, A. L.; Stillmock, K. A.; Schleif, W. A.; Gabryelski, L. J.; Young, S. D. J. Med. Chem. 2000, 43, 4923-4926.
10. Boojamra, C. G.; Burow, K. M.; Thompson, L. A.; Ellman, J. A. J. Qrg. Chem, 1997, 62, 1240-1256.
11. Bilodeau, M. T.; Cunningham, A. M. J. Ore. Chem, 1998, 63, 2800-2801.
12. (a) Walker, M. A.; Ma, Z.; Naidu, B. N.; Sorenson, M. E.; Pendri, A.; Banville, J.; Plamondon, S.; Remillard, R. HIV Integrase Inhibitors. WO 2004004657.
13. (b) Walker, M. A.; Banville, J.; Plamondon, S.; Remillard, R. HIV Integrase Inhibitors. WO 2004004657. For previous methods for the synthesis of pyrrolidinones
14. (a) Pace, P.; Spieser, S. A. H.; Summa, V. Bioorg. Med. Chem. Lett. 2008, 8, 3865-3869.
15. (b) Kawasuji, T.; Fuji, M.; Yoshinaga, T.; Sato, A.; Fujiwara, T.; Kiyama, R. Bioorg, Med, Chem, Lett. 2007, 15, 5487--5492.
16. (c) Davam., R.; Al-Mawsawi, L. Q.; Neamati, N. Bioorg. Med, Chem, Lett. 2007, 17, 6155-6159.
17. (d) Madhav, R.; Snyder, Carroll, A.; Southwick, P. L. J. Heterocvcl, Chem, 1980, 17, 1231-1235.
18. (e) Campbell, J. B.; Firor, J. W. J. Org. Chem. 1995, 60, 7687-7689.
19. (f) Larsen, S. D.; Spilman, C. H.; Bell, F. P.; Dinh, D. M.; Martinborough, E.; Wilson, G. J. J. Med, Chem, 1991, 34, 1721-1727.
20. (g) Mylari, B. L.; Beyer, T. A.; Siegel, T. W. J. Med, Chem. 1991, 34, 1011-1018.
21. (h) Baldwin, J. E.; Chan, M.; Fai; Gallacher, G.; Otsuka, M. Tetrahedron 1984, 40, 4513-4526.
22. (i) Southwick, S. J. Am. Chem. Soc, 1949, 71, 2532-2537.
23. (a) Ma, D.; Ma, J.; Ding, W.; Dai, L. Tetrahedron: Asvmm. 1996, 7, 2365-2370.
24. (b) Besbes, R.; Villieras, M.; Amri, H. Ind. J. Chem, Sect. B: Org. Chem. Incl. Med, Chem. 1997, 36, 5-8.
25. (c) Campbell, S. E.; Comer, M. C.; Derbyshire, P. A.; Despinoy, X. L. M.; Mcnab, H.; Morrisson, R.; Sommerville, C. C.; Thornley, C. J. Chem. Soc. Perkin Trans. 1 1997, 15, 2195-2202.
26. (d) Manabe, K.; Mori, Y.; Kobayashi. S. Synlett 1999, 9, 1401-1402.
27. (a) Kobayashi, S.; Moriwaki, M.; Akiyama, R.; Suzuki, S.; Hachiya, I. Tetrahedron Lett. 1996, 7783-7786.
28. (b) Youngman, M. A.; Dax, S. L. Tetrahedron Lett. 1997, 38, 6347-6350.
29. (c) Jonsson, D.; Molin, H.; Unden, A. Tetrahedron Lett1998, 39, 1059-1062.
30. (d) Zhang, H. C.; Brumfield, K. K.; Jaroslava, I. Tetrahedron Lett. 1998, 39, 4449-4452.
31. Solid phase synthesis of 3-acyl-2,4-pyrrolidinediones was reported using amino acid ester loaded Merrifield resin, an aldehyde and Meldrum's acid. Romoff, T. T.; Ma, L.; Wang, Y.; Campbell, D. A. Synlett 1998, 12, 1341-1342.
32. HPLC conditions: Xterra MS-C1.8 (2.1 × 50 mm); eluted with. 0-100% B, 2.75 min gradient (A. = 100% water-0.1% TFA and B = acetonitrile with 0.1% TFA); flow rate at 1 mL/min.
33. Kyranos. J. N.; Lee, H.; Goetzinger, W. K.; Li, L. Y. T. J. Comb. Chem. 2004, 6, 796-804.
34. Gerritz, S. W.; Sefler, A. M. J. Comb. Chem. 2000, 2, 39-41.
35. (a) Walker, M. A.; Johnson, T.; Ma, Z.; Banville, J.; Remillard, R.; Kim, O.; Zhang, Y.; Staab, A.; Wong, H.; Torri, A.; Samanta, H.; Lin, Z.; Deminie, C.; Terry, B.; Krystal, M.; Meanwell, N. Bioorg., Med. Chem. Lett- 2006, 16, 2920-2924.
36. (b) Engelman, A.; Craigie, R. J. Virol, 1995, 69, 5908-5911.